A Study to Look at Antiepileptic Drug Levels While on Lamictal or Depakote With or Without an Oral Contraceptive
NCT00296413 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 48
Last updated 2017-03-14
Summary
Some antiseizure medication levels are affected by hormones. This study is being done to determine if blood levels of lamotrigine or valproate are affected by the hormones in the birth control pill or the menstrual cycle itself.
Conditions
Sponsors & Collaborators
-
Rhode Island Hospital
collaborator OTHER -
Beth Israel Deaconess Medical Center
lead OTHER
Principal Investigators
-
Andrew G. Herzog, M.D., M.Sc. · Beth Israel Deaconess Medical Center
Eligibility
- Min Age
- 13 Years
- Max Age
- 45 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2006-02-28
- Primary Completion
- 2009-02-28
- Completion
- 2009-02-28
Countries
- United States
Study Locations
More Related Trials
-
Drug Use Investigation for LAMICTAL
NCT01376180 ·Status: COMPLETED
-
Women With Epilepsy: a Pilot Study of PK and PD Anti-epileptic Drug Effects in Levonorgestrel Intrauterine System Users
NCT02362373 ·Status: COMPLETED ·Phase: PHASE4
-
Observational Study of Lamotrigine
NCT00299793 ·Status: COMPLETED
-
Role of Hormones in Susceptibility to Seizures in Women With Epilepsy
NCT00044252 ·Status: COMPLETED
-
Progesterone vs Placebo Therapy for Women With Epilepsy
NCT00029536 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Test the Interaction of Padsevonil With Oral Contraceptives in Healthy Female Participants
NCT04131517 ·Status: TERMINATED ·Phase: PHASE1
-
Hormone Profiles in Adults With Newly Diagnosed Epilepsy
NCT00137709 ·Status: UNKNOWN ·Phase: PHASE4
-
Epilepsy Birth Control Registry
NCT01097837 ·Status: UNKNOWN
-
Effect of Repeat Administration of Eslicarbazepine Acetate on the Pharmacokinetics of a Combined Oral Contraceptive
NCT00898560 ·Status: COMPLETED ·Phase: PHASE1
-
Conversion To Monotherapy With Lamictal Extended Release Tablets For Treatment Of Partial Epilepsy
NCT00355082 ·Status: COMPLETED ·Phase: PHASE3
-
Characterization of Epilepsy Patients BEEP 2b
NCT02707965 ·Status: COMPLETED ·Phase: PHASE1
-
Effect of Anti-epileptic Drugs on Etonogestrel-releasing Implant Pharmacokinetics in Women With Epilepsy
NCT03307863 ·Status: SUSPENDED ·Phase: PHASE4
-
Study of Diazepam Buccal Film Administered in the Interictal and in the Ictal-Periictal States to Adults With Epilepsy
NCT03179891 ·Status: COMPLETED ·Phase: PHASE2
-
LAMICTAL (Lamotrigine) For The Treatment Of Absence Seizures
NCT00144872 ·Status: COMPLETED ·Phase: PHASE1
-
Special Drug Use Investigation for LAMICTAL® (Long Term)
NCT01863602 ·Status: COMPLETED
-
An Observational Study of Epilepsy: Biology and Outcomes Using Real-world Data
NCT05632978 ·Status: RECRUITING
-
Open-label Drug Interaction Study Between Eslicarbazepine Acetate and Lamotrigine.
NCT02283801 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacokinetics of Anti-epileptic Drugs in Obese Children
NCT02993861 ·Status: COMPLETED
-
Women With Epilepsy: Pregnancy Outcomes and Deliveries
NCT01259310 ·Status: COMPLETED
-
Safety and Tolerability Study of Diazepam Buccal Film (DBF) in Subjects With Epilepsy
NCT03428360 ·Status: COMPLETED ·Phase: PHASE3
-
Maternal Outcomes and Neurodevelopmental Effects of Antiepileptic Drugs (MONEAD)
NCT01730170 ·Status: COMPLETED
-
Compliance With Once-Daily Divalproex Extended-Release Tablets (Depakote-ER) Versus Multiple-Daily Dose Valproic Acid Capsules (Depakene) in Epilepsy:
NCT00356018 ·Status: COMPLETED
-
Valproate Dose Reduction and Its Clinical Evaluation by Introducing Lamotrigine in Japanese Women With Epilepsy - Single Arm, Multicenter, and Open-label Study
NCT02100644 ·Status: COMPLETED ·Phase: PHASE4
-
A Study in Participants With Epilepsy, to Evaluate the Pharmacokinetics, Safety and Tolerability of Oxcarbazepine on Padsevonil
NCT03695094 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Evaluate Pharmacokinetics and Tolerability of Multiple Doses of Eslicarbazepine Acetate and Oxcarbazepine
NCT00900237 ·Status: COMPLETED ·Phase: PHASE1